$SEDG

Intuit downgraded, SolarEdge upgraded: Wall Street's top analyst calls

UBS upgraded SolarEdge (SEDG) to Buy with a $42 target, citing FCC benefits. Wolfe upgraded DT Midstream (DTM) to Outperform with a $145 target. Piper upgraded Neogen (NEOG) to Overweight with a $14 target. UBS upgraded Argenx (ARGX) to Buy with a $1,400 target. National Bank upgraded Scotiabank (BNS) to Outperform with a C$142 target. JPMorgan and BofA downgraded Intuit (INTU) to Neutral with a $331 target. Truist downgraded Dick's Sporting (DKS) and Nike (NKE). Wells downgraded GoDaddy (GDDY).

Original reporting
Published Aug 27, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 10:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Intuit downgraded, SolarEdge upgraded: Wall Street's top analyst calls — source image
Decision brief

The 30-second read

$SEDGBullishMed
01

Why it matters

The mixed rating changes suggest selective optimism, with tech and biotech receiving upgrades while consumer and software firms face downgrades.

02

Market read

These rating changes could drive short-term price moves in the affected stocks.

03

What to watch

Potential macro headwinds could offset analyst optimism.

Relevance 5/10Novelty 4/10Timing: today

Background

A series of analyst upgrades and downgrades were announced across multiple sectors.

Company-level read

Ticker impact

$SEDGBullishMedium confidence
Context

UBS upgraded SolarEdge to Buy from Neutral with a $42 price target.

Expected impact

Modest price increase expected.

Evidence & confidence

Upgrade signals improved outlook.

$DTMBullishMedium confidence
Context

Wolfe Research upgraded DT Midstream to Outperform from Peer Perform with a $145 target.

Expected impact

Small upside potential.

Evidence & confidence

Analyst view upgrade.

$NEOGBullishMedium confidence
Context

Piper Sandler upgraded Neogen to Overweight from Neutral with a $14 target.

Expected impact

Limited upside.

Evidence & confidence

Positive earnings trend noted.

$ARGXBullishMedium confidence
Context

UBS upgraded Argenx to Buy from Neutral with a $1,400 target.

Expected impact

Potential moderate gain.

Evidence & confidence

Strong drug pipeline highlighted.

$INTUBearishMedium confidence
Context

JPMorgan downgraded Intuit to Neutral from Overweight with a $331 target.

Expected impact

Possible short-term decline.

Evidence & confidence

AI disruption risks cited.

$DKSBearishMedium confidence
Context

Truist downgraded Dick's Sporting to Hold from Buy with a $135 target.

Expected impact

Likely downside pressure.

Evidence & confidence

Lower fiscal guidance noted.

$NKEBearishMedium confidence
Context

Truist downgraded Nike to Hold from Buy with a $42 target.

Expected impact

Modest downside risk.

Evidence & confidence

Turnaround progress questioned.

$GDDYBearishMedium confidence
Context

Wells Fargo downgraded GoDaddy to Underweight from Equal Weight with a $76 target.

Expected impact

Potential short-term decline.

Evidence & confidence

AI competition concerns.

Market effects

Analyst upgrades may lift broader tech and industrial sectors.

US equity sentiment could improve modestly.

Limited global impact; primarily US market.

Counterpoint

Some upgrades may be premature given broader market volatility.

Key entities

  • UBS

    Provided upgrades for SolarEdge and Argenx.

  • JPMorgan

    Downgraded Intuit.

Related articles

$ELMedAI 8/10

Estee Lauder vs Nike: One Turnaround Just Proved Itself, the Other Keeps Slipping

Estee Lauder (EL) reported four consecutive earnings beats, raising its fiscal 2027 EPS guidance to $3.10-$3.35. Nike (NKE) guided revenue down, with Greater China down 12% and Converse down 32%. EL's stock rose 10.46% post-earnings, while NKE's turnaround timeline extends. EL's forward P/E is near 32, with a 1.3% yield. NKE offers a 4.3% yield but faces declining revenue.

$INTUMed

Intuit (INTU) is Lowering TurboTax Revenue per User to Win Customers. Can the Strategy Restore Double-Digit Growth?

Intuit (INTU) reported fiscal 2026 revenue of $21.4B, up 14%, but expects slower growth in 2027 (9-10%). The company plans to lower TurboTax revenue per user to attract more customers, aiming to offset this with higher-value services like TurboTax Live and Credit Karma. Intuit has $7.2B in cash and investments, with a strong dividend and share buyback program. However, TurboTax units declined 2%, and the strategy's success depends on retaining new customers and increasing cross-selling.

$ARGXHighAI 8/10

argenx (ENXTBR:ARGX) Just Gave Investors Something To Think About

argenx (ARGX) reported positive Phase 3 trial results for VYVGART Hytrulo in treating autoimmune myositis. Shares have surged, with a 1-year return of 50.58%. Analysts debate valuation, with some calling it 32.2% overvalued at €907.40, while others see a 52.2% discount. Investors should watch for clinical setbacks and pricing pressures.

$INTUMedAI 8/10

INTU Q2 Deep Dive: AI Strategy and Customer Acquisition Take Center Stage

Intuit reported Q2 revenue of $4.35B, beating estimates, with 13.7% YoY growth. Adjusted EPS of $4.03 also beat estimates. Q3 revenue guidance of $4.31B is below expectations, and FY2027 EPS guidance misses estimates. Operating margin improved to 17.6%. The company highlighted mid-market revenue growth, AI adoption, and new customer acquisition strategies. Management expects short-term margin pressure due to increased investment in customer acquisition and competitive pricing adjustments.